These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The influence of hallucinogenic drugs upon in vivo brain levels of adenine nucleotides, phosphocreatine and inorganic phosphate in the rat. Lewis JJ, Ritchie AP, van Petten GR. Br J Pharmacol Chemother; 1965 Dec; 25(3):631-7. PubMed ID: 5296835 [No Abstract] [Full Text] [Related]
16. Vasoconstriction produced by hallucinogens on isolated human and sheep umbilical vasculature. Dyer DC, Gant DW. J Pharmacol Exp Ther; 1973 Feb; 184(2):366-75. PubMed ID: 4347258 [No Abstract] [Full Text] [Related]
17. A behavioral and pharmacological analysis of some discriminable properties of d-LSD in rats. Cameron OG, Appel JB. Psychopharmacologia; 1973 Feb; 33(2):117-34. PubMed ID: 4272898 [No Abstract] [Full Text] [Related]
18. A comparison of psychotomimetic drug effects on rat brain norepinephrine metabolism. Stolk JM, Barchas JD, Goldstein M, Boggan W, Freedman DX. J Pharmacol Exp Ther; 1974 Apr; 189(1):42-50. PubMed ID: 4823298 [No Abstract] [Full Text] [Related]
19. Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'. Koerner J, Appel JB. Psychopharmacology (Berl); 1982 Apr; 76(2):130-5. PubMed ID: 6805022 [Abstract] [Full Text] [Related]
20. Inhibition of isolation-induced attack behavior of mice by drugs. Uyeno ET. J Pharm Sci; 1966 Feb; 55(2):215-6. PubMed ID: 5923276 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]